Peptides and Nucleic Acid Therapeutics: Dancing a Triumphant Tango

Learn about the clinical potential of nucleic acid therapeutics.

Increasing advances in genetics and bioengineering technologies have made gene therapy more accessible than ever before.

The field of nucleic acid therapeutics, which is based on DNA, RNA, or closely related chemical compounds, is seen as promising for the treatment of genetic disorders and other diseases, including cancer, infectious, inflammatory, and neurodegenerative diseases.

More about this report:

In this report, we discuss the clinical potential of nucleic acid therapeutics and how they can be delivered safely to the region of interest. We will also take a look at the future of nucleic acid therapeutics and how related drug delivery systems will be advancing too.

Peptides and nucleic acid therapeutics
Share:

Report 13: Peptides and Nucleic Acid Therapeutics: Dancing a Triumphant Tango

"*" indicates required fields

Name*
Address*
By clicking this I agree to receive Labiotech's newsletter and understand that my personal data will be processed according to the Privacy Policy.*
This field is for validation purposes and should be left unchanged.